Hangzhou Tigermed Consulting Co., Ltd. announced its 2026 interim results, showcasing impressive financial performance. During the reporting period, Tigermed’s revenue reached RMB 3,707.6 million, a 14.1% increase year-over-year. The company also saw growth in other key financial metrics, with gross profit up 4.4% YoY and adjusted net profit attributable to the owners rising by 31.8% YoY. Notably, Tigermed’s China revenue surged by 24.0% YoY to RMB 2,106.1 million, while overseas revenue also saw a positive trend, increasing by 3.2% YoY.
News Timeline:
Track the development of this news story across the Internet.